Prot# GS-US-426-3989: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-0976 in Subjects with Nonalcoholic Steatohepatitis

Project: Research project

Project Details

StatusFinished
Effective start/end date9/14/169/14/19

Funding

  • PRA Health Sciences (Prot# GS-US-426-3989)
  • Gilead Sciences, Inc. (Prot# GS-US-426-3989)